Scipio bioscience develops a new generation of sample preparation solution for single-cell studies, in the form of user-friendly and cost-effective benchtop kits, for use in sequencing applications in clinical and basic research, with an initial focus on transcriptomics. Scipio Bioscience has developed the protocol from the initial proof-of-concept studies to a prototype kit ready for beta-testing in collaboration with several research teams. The company, founded in 2017, is hosted in the iPEPS-ICM incubator of the Brain & Spine Institute (ICM, Pitié-Salpêtrière Hospital, Paris).
Location: France, Ile-de-France
Employees: 11-50
Total raised: $8.68M
Founded date: 2017
Investors 2
Date | Name | Website |
08.11.2022 | M Ventures | m-ventures... |
- | Verve Vent... | verve.vc |
Funding Rounds 2
Date | Series | Amount | Investors |
25.02.2020 | Series A | $7.27M | - |
14.11.2017 | Seed | $1.41M | - |
Mentions in press and media 5
Date | Title | Description | Source |
25.02.2020 | Scipio bioscience Secures €6.0M Series A Financing | Scipio bioscience, a Paris, France-based biotechnology company developing a new generation of single... | finsmes.co... |
14.11.2017 | Scipio bioscience Raises €1.2m in Seed Funding | Scipio bioscience, a Paris, France-based biotechnology company, raised €1.2m in seed funding. Backe... | finsmes.co... |
14.11.2017 | Scipio bioscience announces its seed funding of €1.2m obtain... | Scipio bioscience, a Paris-based biotechnology company devoted to providing a novel sample preparati... | seventure.... |
- | Scipio bioscience raises €6.0 M Series A financing | Paris, 25 February 2020 - Scipio bioscience, a Paris-based biotechnology company, developing a new g... | m-ventures... |
- | Scipio bioscience raises €6.0 M Series A financing to develo... | February 25, 2020 Scipio bioscience, a Paris-based biotechnology company, developing a new generati... | htgf.de/en... |